LEA LEIV 4
4 · Corvus Pharmaceuticals, Inc. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-03-16$1.54/sh+35,160$54,146→ 85,360 total(indirect: By IRA) - Purchase
Common Stock
2022-03-17$1.65/sh+13,878$22,899→ 99,238 total(indirect: By IRA)
Holdings
- 149,206(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.60 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by Leiv Lea IRA Contributory.
- [F3]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.62 to $1.66 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.